Professor, Psychiatry and Behavioral Neuroscience, Loyola University of Chi Stritch School of Medicine
Psychiatry
Dr. Angelos Halaris, MD
|
|
Give Review
Angelos Halaris practices Psychiatry. He over the years received 2 awards: "West Suburban Living Magazine" and "CMS Meaningful Use Stage 1 Certification". Angelos Halaris is a published doctor. He has 101 papers published. The most current publication "Alpha 2-adrenoceptors and I1-imidazoline binding sites: relationship with catecholamines in women of reproductive age." He accepts Medicare.
Publications
- Shared neurobiological pathways between type 2 diabetes and Depressive symptoms: a review of morphological and neurocognitive findings.
- Vascular Endothelial Growth Factor: A potential diagnostic biomarker for Major depression.
- Medical students' interest in pursuing psychiatry residency: a 5-year analysis of a consultation psychiatry clerkship educational module.
- Inflammation, heart disease, and depression.
- Agmatine: clinical applications after 100 years in translation.
- Psychocardiology: moving toward a new subspecialty.
- Antidepressant Drugs affect dopamine uptake.
- Psychotropic Drugs and dopamine uptake inhibition.
- Hippocampal innervation by serotonin neurons of the midbrain raphe in the rat.
- Axonal transport in serotonin neurons of the midbrain raphe.
- Ascending projections of the locus coeruleus in the rat. I. Axonal transport in central noradrenaline neurons.
- Noradrenaline metabolism in a manic-Depressive patient.
- Serotonin neurons of the midbrain raphe: ascending projections.
- Effects of locus coeruleus lesions upon cerebral monoamine content, sleep-wakefulness states and the response to amphetamine in the cat.
- Supersensitivity to norepinephrine or dopamine antagonists after knife cuts that produce aphagia and adipsia in rats.
- A correlational analysis of the effects of surgical transections of three components of the MFB on ingestive behavior and hypothalamic, striatal, and telencephalic ami...
- Variations in the uptake of 3H-norepinephrine during the rat estrous cycle.
- Plasma 3-methoxy-4-hydroxyphenylglycol in manic Psychosis.
- Active uptake of [3H]5-HT by synaptic vesicles from rat brain.
- Post-ECT asterixis associated with primary hyperparathyroidism.
- Aphagia and adipsia after preferential destruction of nerve cell bodies in hypothalamus.
- Indoleamine compartmentation in human blood.
- Origin and distribution of 3-methoxy-4-hydroxyphenylglycol in body fluids.
- Determination of plasma 3-methoxy-4-hydroxyphenyl-glycol by pulsed electron capture gas chromatography.
- Effects of tricyclic antidepressants on acetylcholine turnover and choline uptake [proceedings].
- Effects of the potential antidepressant AHR-1118 on amine uptake and on plasma 3-methoxy-4-hydroxyphenylglycol in manic-Depressive illness [proceedings].
- Variations in the uptake of 3H-dopamine during the estrous cycle.
- Vesicular and juxtavesicular serotonin: effects of lysergic acid diethylamide and reserpine.
- Some biochemical effects of zona incerta lesions that interfere with the regulation of water intake.
- Loss of body weight as a predictor of reserpine-induced amine depletion.
- Plasma corticoids and brain tryptophan after acute and tolerance dosage of LSD.
- Reduced neuropeptide Y concentrations in suicide brain.
- Interactions between neuropeptide Y and alpha 2-adrenoceptors in selective rat brain regions.
- Chronic desipramine treatment reduces regional neuropeptide Y binding to Y2-type receptors in rat brain.
- Rat brain de-acetylating activity: stereospecific inhibition by LSD and serotonin-related compounds.
- CSF and endocrine studies of premenstrual syndrome.
- Apparent phase advance in diurnal MHPG rhythm in depression.
- The relationship between life Stress and depression in an endogenous sample.
- Effects of neuropeptide Y on alpha 1-and beta-adrenoceptor-stimulated second messenger systems in rat frontal cortex.
- A comparison of the binding of [3H]proprionyl-neuropeptide Y to rat and human frontal cortical membranes.
- Diurnal rhythm of 3-methoxy-4-hydroxyphenylglycol (MHPG): relationship between plasma and urinary levels.
- Effect of chlorimipramine on the metabolism of 5-hydroxytryptamine in the rat brain.
- Ultrastructural changes in the gastric mucosa after truncal vagotomy.
- Mucosal vasculature after truncal vagotomy.
- The raphe neuronal system and serotonergic effects of LSD.
- Nerve terminal effects of indoleamine psychotomimetics on 5-hydroxytryptamine.
- Evaluation of the safety and efficacy of bupropion in depression.
- Bupropion in depression: a tri-center placebo-Controlled study.
- Lithium therapy.
- Clinical efficacy of the new antidepressant bupropion (Wellbutrin) [proceedings].
- Effects of desipramine on diurnal rhythms of plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) in depressed patients.
- Central cholinergic effects of tricyclic antidepressants in mouse.
- Rat brain aryl acylamidase: further characterization of multiple forms.
- Noncompetitive amine uptake inhibition by the new antidepressant pridefine.
- Open trial evaluation of a pyrrolidine derivative (AHR-1118) on norepinephrine metabolism.
- Compartmentation of catecholamines in rat brain: effects of agonists and antagonists.
- Action of the antidepressant pridefine (AHR-1118) on biogenic amines in the rat brain.
- Platelet I1-imidazoline binding sites are decreased by two dissimilar antidepressant agents in depressed patients.
- Determination of agmatine in brain and plasma using high-performance liquid chromatography with fluorescence detection.
- Characterization of subtypes of alpha-2 adrenoceptors in the human brain.
- Predicting response to fluoxetine in geriatric patients with Major depression.
- Rat brain aryl acylamidase: multiple forms and inhibition effects of LSD, serotonin and related compounds.
- Innervation of forebrain regions by medullary noradrenaline neurons, a biochemical study in cats with central tegMental tract lesions.
- Differential expression of alpha2-adrenoceptor vs. imidazoline binding sites in postmortem orbitofrontal cortex and amygdala of depressed subjects.
- Effect of agmatine against cell death induced by NMDA and glutamate in neurons and PC12 cells.
- Pro-inflammatory biomakers in depression: treatment with venlafaxine.
- Agmatine : metabolic pathway and spectrum of activity in brain.
- Platelet imidazoline receptors as state marker of Depressive symptomatology.
- Down-regulation of platelet imidazoline-1-binding sites after bupropion treatment.
- Neurochemical aspects of the sexual response cycle.
- Persistent disturbance of the hypothalamic-pituitary-gonadal axis in abstinent Alcoholic men.
- Combination therapy or monotherapy for the depressed type of schizoaffective Disorder.
- A primary care focus on the diagnosis and treatment of major depressive Disorder in adults.
- Multimodality imaging in a depressed patient with violent behavior and temporal lobe seizures.
- Comorbidity between depression and cardiovascular disease.
- Depression and atherosclerosis.
- Relevance of imidazoline receptors and agmatine to psychiatry: a decade of progress.
- Atypical [(3)H]clonidine binding sites in human caudate and platelets on cryostat-cut sections.
- Psychopharmacology of imidazoline and alpha 2-adrenergic receptors: implications for depression.
- Platelet I1-imidazoline binding sites are elevated in depression but not generalized anxiety Disorder.
- Chronic imipramine treatment downregulates IR1-imidazoline receptors in rat brainstem.
- Plasma MHPG response to yohimbine treatment in women with hypoactive sexual desire.
- A 2-year study of sertraline in the treatment of obsessive-compulsive Disorder.
- Alpha 2-adrenoceptors and I1-imidazoline binding sites: relationship with catecholamines in women of reproductive age.
- Effect of bupropion on immunodensity of putative imidazoline receptors on platelets of depressed patients.
- Plasma agmatine and platelet imidazoline receptors in depression.
- Psychoendocrine sequelae of chronic testosterone deficiency.
- Sucrose and quinine intake by maternally-deprived and Control rhesus monkeys.
- Autoradiographic comparison of [3H]-clonidine binding to non-adrenergic sites and alpha(2)-adrenergic receptors in human brain.
- Imidazoline receptor proteins are decreased in the hippocampus of individuals with Major depression.
- Elevated P-selectin on platelets in depression: response to bupropion.
- Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar Disorder.
- Circadian rhythm of vital signs, norepinephrine, epinephrine, thyroid hormones, and cortisol in Schizophrenia.
- A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive Disorder.
- Involvement of I1-imidazoline receptors in mood Disorders.
- Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive Disorder.
- Increased imidazoline and alpha 2 adrenergic binding in platelets of women with dysphoric premenstrual syndromes.
- Circadian rhythm of tryptophan, serotonin, melatonin, and pituitary hormones in Schizophrenia.
- Agonist binding to alpha 2-adrenoceptors is elevated in the locus coeruleus from victims of suicide.
- Disruption of circadian MHPG rhythmicity in Major depression.
Schools
Ludwig Maximiliams University Medical Faculty
University Munich Hosps Clins
Chicago
Procedures Preformed
- Psychiatric Medication Therapy
Conditions Treated
- Adjustment Disorder
- Anxiety
- Attention Deficit Hyperactivity Disorder (ADHD)
- Autism
- View All
Doctors Specialties
- Psychiatry
Accepted Insurances
Awards
- West Suburban Living Magazine
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Chicago -
Ludwig Maximilian University of Munich Faculty of Medicine
Hospital
-
Sarah Bush Lincoln Health Center
Drug Facts
| NPI NUMBER | 1891762621 | |
| NPPES Provider LastName | HALARIS | |
| NPPES Provider FirstName | ANGELOS | |
| NPPES Provider ZIPCode | 60153 | |
| NPPES Provider State | IL | |
| Specialty Description | Psychiatry | |
| Total Claim Count | 273.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1891762621 |
| Last Name Of The Provider | HALARIS |
| First Name Of The Provider | ANGELOS |
| View All |
Similar Doctors
|
|
Dr. Aparna Sharma, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Domeena C. Renshaw, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edwin Meresh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ricky I. Singh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Huma A. Khan, MD |
|
|
Dr. Christine A. Figiel, DO |
|
|
Dr. Kimberly Sanders, MD
This Doctor is OpenDoctor Recommended.
|